Your Blood Pressure Drops Too Easily. Your Genes May Control It.

The ACE gene produces an enzyme that converts angiotensin I into angiotensin II, a powerful hormone that tells your blood vessels to constrict. This is a critical part of your body’s emergency response system. When your blood pressure drops, ACE activation should kick in and bring it back up. The stronger your ACE activity, the more aggressively your blood vessels respond to this signal.

The ACE I/D polymorphism creates two functional versions of this enzyme. People with the D/D genotype, carried by roughly 25% of people with European ancestry, produce more ACE enzyme and have higher baseline activity. But here’s the catch: if you carry the I/I genotype instead, your body produces less ACE, meaning your emergency blood pressure response is weaker. Your vessels don’t constrict as aggressively when you stand up or face stress.

What this means for you: if you have the I/I genotype, you may feel lightheaded when you stand, struggle with exercise tolerance, or experience brain fog that improves only when you lie down. Your body simply can’t generate the vessel constriction force that others take for granted. Salt loading and staying horizontal help temporarily, but they’re workarounds for a genetics problem.

AGT is the starting material that ACE converts into angiotensin II. Your body produces angiotensinogen constantly in the liver, and the amount you produce is partly genetic. Higher AGT levels mean more raw material available for conversion into the hormone that raises blood pressure. This is your body’s fuel tank for blood pressure regulation.

The M235T variant determines how much AGT your liver produces. If you carry the M235T or T235T genotype, found in roughly 40% of people, your body cranks out more angiotensinogen. This normally leads to higher blood pressure because you have more substrate available for converting into angiotensin II. But if you also carry low-activity ACE variants, or if your blood vessels don’t respond well to angiotensin II, you end up with a mismatch: high angiotensinogen but weak downstream signaling.

What this means for you: you may feel that your body is trying hard to raise your blood pressure but not succeeding. You experience the hormonal effort (sometimes as fatigue or stress response activation) without the actual pressure increase. The result is a dysregulated system that leaves you dizzy and exhausted.

AGTR1 produces the receptor on your blood vessel walls that catches the angiotensin II signal and tells the vessel to constrict. This is the lock that receives the key. If your receptors are sensitive and responsive, a little bit of angiotensin II causes powerful constriction. If they’re less responsive, you need more signal to achieve the same effect.

The A1166C variant changes how readily your blood vessels respond to this signal. If you carry the C allele, found in roughly 30% of people, your blood vessel receptors are less sensitive to angiotensin II, meaning your vessels don’t constrict as aggressively even when hormone levels are high. You have the chemical signal, but your tissues aren’t listening as well.

What this means for you: even when your body floods your system with angiotensin II trying to raise your blood pressure, your blood vessels don’t respond proportionally. This is especially noticeable when you stand or exercise. Your heart races to compensate, but the vessels stay too relaxed. You feel your pulse pounding in your head but don’t feel blood pressure building.

ADD1 controls a protein that manages how much sodium your kidneys reabsorb. Sodium is the foundation of blood pressure. More sodium means more water retention, which means higher blood volume and higher pressure. Your kidneys can be set to either save sodium aggressively or let it flow into urine. ADD1 helps determine which mode your kidneys stay in.

The G460W variant determines how efficiently your kidneys hold onto sodium. If you carry the W allele, present in roughly 25% of people, your kidneys are less effective at reabsorbing sodium, meaning you lose more salt in your urine. This is salt sensitivity in reverse: your body is salt-wasting rather than salt-retaining. Where others can regulate blood pressure even on low-sodium diets, your kidneys are constantly draining the sodium pool.

What this means for you: you have an intense craving for salty foods because your body is desperately trying to compensate. You may have been told to cut salt, which makes your symptoms worse because you actually need more. Your blood volume is chronically lower than it should be, leaving your blood pressure baseline too low. You feel exhausted partly because your heart is working harder to push a smaller volume of fluid.

CYP11B2 produces the enzyme that synthesizes aldosterone, the hormone that directly tells your kidneys to hold onto sodium and excrete potassium. Aldosterone is your body’s most powerful sodium-retaining signal. When aldosterone is high, your kidneys cling to every sodium molecule. When it’s low, sodium pours into your urine.

The -344C>T variant affects how active your CYP11B2 enzyme is. If you carry the T allele, found in roughly 40% of people, your body produces more aldosterone, meaning your kidneys work harder to hold onto sodium and raise blood volume. But this effect is subtle and slow. Where someone with a dominant D allele ACE might experience acute blood pressure changes, you experience chronic sodium and water retention that gradually builds up over days.

What this means for you: if you also carry variants in ADD1 or AGTR1 that push your blood pressure down, a high-aldosterone CYP11B2 variant might partially counterbalance the effect. But if multiple low-pressure genes stack up, even high aldosterone may not be enough to maintain adequate blood pressure. You live in a state of constant metabolic effort, trying to retain enough sodium to stay functional.

NOS3 produces nitric oxide, the gas that tells your blood vessels to relax and dilate. This is the counterbalance to ACE and angiotensin II. When your vessels need to open up to allow more blood flow (during exercise, recovery, or normal circulation), nitric oxide is the signal that makes it happen. A healthy NOS3 system keeps your vessels flexible and responsive.

The Glu298Asp variant changes how much nitric oxide your endothelial cells produce. If you carry the Asp variant, found in roughly 30-40% of people, your cells generate less nitric oxide, meaning your blood vessels stay more constricted at baseline and have less ability to relax. This sounds like it would raise blood pressure, but the mechanism is more complex: less nitric oxide also means less feedback to relax vessels, so the constrictor systems work harder with less opposition.

What this means for you: combined with other low-pressure variants, a low-nitric-oxide NOS3 variant means your blood vessels are already somewhat tense, but they can’t generate the sharp constriction response your body needs when you stand or face stress. It’s like driving a car with the brake partially engaged. The engine works harder but can’t generate full power when needed.